Cassava Sciences Inc. | PTIE - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Cassava Sciences Inc.

Cassava Sciences Inc. reported $7.06M in Current Liabilities for its fiscal quarter ending in December of 2022.


Current Liabilities Change
Abbott ABT:US USD 14.53B 959M
Amgen AMGN:US USD 14.22B 1.47B
Biogen BIIB:US USD 3.01B 257.9M
Cara Therapeutics CARA:US USD 16.68M 6.78M
Eisai 4523:JP JPY 298.94B 14.73B
Eli Lilly LLY:US USD 16.01B 1.13B
Geron GERN:US USD 43.91M 32.78M
J&J JNJ:US USD 60.37B 4.57B
Novartis NOVN:VX USD 30.55B 1.89B
Novavax NVAX:US USD 1.92B 541.09M
Roche Holding ROG:VX 27.24B 170M